Effects of renal chronic kidney disease and contrast-induced nephropathy on prognosis and treatment outcomes of acute coronary syndromes

[1]  E. Topol,et al.  Bivalirudin versus heparin and glycoprotein IIb/IIIa inhibition among patients with renal impairment undergoing percutaneous coronary intervention (a subanalysis of the REPLACE-2 trial). , 2005, The American journal of cardiology.

[2]  F. Veglia,et al.  Contrast-induced nephropathy in patients undergoing primary angioplasty for acute myocardial infarction. , 2004, Journal of the American College of Cardiology.

[3]  E. Antman,et al.  Association of glomerular filtration rate on presentation with subsequent mortality in non-ST-segment elevation acute coronary syndrome; observations in 13,307 patients in five TIMI trials. , 2004, European heart journal.

[4]  R. Gupta,et al.  The renal patient with coronary artery disease: current concepts and dilemmas. , 2004, Journal of the American College of Cardiology.

[5]  G. Stone,et al.  A simple risk score for prediction of contrast-induced nephropathy after percutaneous coronary intervention: development and initial validation. , 2004, Journal of the American College of Cardiology.

[6]  Robert M Califf,et al.  Relation between renal dysfunction and cardiovascular outcomes after myocardial infarction. , 2004, The New England journal of medicine.

[7]  Charles E McCulloch,et al.  Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. , 2004, The New England journal of medicine.

[8]  F. Neumann,et al.  Renal function and long term mortality after unstable angina/non-ST segment elevation myocardial infarction treated very early and predominantly with percutaneous coronary intervention , 2004, Heart.

[9]  E. Topol,et al.  Double jeopardy of renal insufficiency and anemia in patients undergoing percutaneous coronary interventions. , 2004, The American journal of cardiology.

[10]  K. Harjai,et al.  Impact of nephropathy after percutaneous coronary intervention and a method for risk stratification. , 2004, The American journal of cardiology.

[11]  H. Kasanuki,et al.  Prognostic significance of serum creatinine concentration for in-hospital mortality in patients with acute myocardial infarction who underwent successful primary percutaneous coronary intervention (from the Heart Institute of Japan Acute Myocardial Infarction [HIJAMI] Registry). , 2004, The American journal of cardiology.

[12]  J. Rumsfeld,et al.  Renal insufficiency and mortality from acute coronary syndromes. , 2004, American heart journal.

[13]  R. Giugliano,et al.  The Prognostic Value of Serum Creatinine on Admission in Fibrinolytic-Eligible Patients with Acute Myocardial Infarction , 2003, Journal of Thrombosis and Thrombolysis.

[14]  J. J. Griffin,et al.  Impact of Renal Insufficiency in Patients Undergoing Primary Angioplasty for Acute Myocardial Infarction , 2003, Circulation.

[15]  A. Jacobs,et al.  Renal insufficiency is an independent predictor of mortality after percutaneous coronary intervention , 2003 .

[16]  W. French,et al.  Renal insufficiency and worsened prognosis with STEMI: a call for action. , 2003, Journal of the American College of Cardiology.

[17]  E. Antman,et al.  Association of creatinine and creatinine clearance on presentation in acute myocardial infarction with subsequent mortality. , 2003, Journal of the American College of Cardiology.

[18]  Deepak L. Bhatt,et al.  Bivalirudin provides increasing benefit with decreasing renal function: a meta-analysis of randomized trials. , 2003, The American journal of cardiology.

[19]  A. Sadaniantz,et al.  Review of antithrombotic agents used for acute coronary syndromes in renal patients. , 2003, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[20]  S. Borzak,et al.  Analysis of long-term survival after revascularization in patients with chronic kidney disease presenting with acute coronary syndromes. , 2003, The American journal of cardiology.

[21]  J. Gore,et al.  Creatinine clearance and adverse hospital outcomes in patients with acute coronary syndromes: findings from the global registry of acute coronary events (GRACE) , 2003, Heart.

[22]  R. Califf,et al.  N‐Terminal Pro‐Brain Natriuretic Peptide and Other Risk Markers for the Separate Prediction of Mortality and Subsequent Myocardial Infarction in Patients With Unstable Coronary Artery Disease: A Global Utilization of Strategies To Open occluded arteries (GUSTO)‐IV Substudy , 2003, Circulation.

[23]  H. Krumholz,et al.  Aspirin, beta-blocker, and angiotensin-converting enzyme inhibitor therapy in patients with end-stage renal disease and an acute myocardial infarction. , 2003, Journal of the American College of Cardiology.

[24]  A. Donker,et al.  Impaired renal function is associated with markers of endothelial dysfunction and increased inflammatory activity. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[25]  J. Cooper,et al.  Renal function and risk stratification in acute coronary syndromes. , 2003, The American journal of cardiology.

[26]  K. Eagle,et al.  Influence of concurrent renal dysfunction on outcomes of patients with acute coronary syndromes and implications of the use of glycoprotein IIb/IIIa inhibitors. , 2003, Journal of the American College of Cardiology.

[27]  E. Braunwald,et al.  Effects of renal insufficiency on early invasive management in patients with acute coronary syndromes (The TACTICS-TIMI 18 Trial). , 2002, The American journal of cardiology.

[28]  G. Specchia,et al.  Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation. , 2002, European heart journal.

[29]  A. Jaffe,et al.  Acute Myocardial Infarction and Renal Dysfunction: A High-Risk Combination , 2002, Annals of Internal Medicine.

[30]  M. Mcclellan,et al.  Association of Renal Insufficiency with Treatment and Outcomes after Myocardial Infarction in Elderly Patients , 2002, Annals of Internal Medicine.

[31]  K. Fox,et al.  Interventional versus conservative treatment for patients with unstable angina or non-ST-elevation myocardial infarction: the British Heart Foundation RITA 3 randomised trial , 2002, The Lancet.

[32]  B. Brendorp,et al.  The prognostic importance of creatinine clearance after acute myocardial infarction. , 2002, European heart journal.

[33]  J. J. Griffin,et al.  Comparison of angioplasty with stenting, with or without abciximab, in acute myocardial infarction. , 2002, The New England journal of medicine.

[34]  E. Braunwald,et al.  Comparison of early invasive and conservative strategies in patients with unstable coronary syndromes treated with the glycoprotein IIb/IIIa inhibitor tirofiban. , 2001, The New England journal of medicine.

[35]  J. Yee,et al.  Determinants of mortality after myocardial infarction in patients with advanced renal dysfunction. , 2001, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[36]  M. Mcclellan,et al.  Comparison of the effects of angiotensin converting-enzyme inhibitors and beta blockers on survival in elderly patients with reduced left ventricular function after myocardial infarction. , 2001, The American journal of medicine.

[37]  G. Dangas,et al.  The prognostic implications of further renal function deterioration within 48 h of interventional coronary procedures in patients with pre-existent chronic renal insufficiency. , 2000, Journal of the American College of Cardiology.

[38]  Deepak L. Bhatt,et al.  Current role of platelet glycoprotein IIb/IIIa inhibitors in acute coronary syndromes. , 2000, JAMA.

[39]  M. Mcclellan,et al.  Are we inhibited? Renal insufficiency should not preclude the use of ACE inhibitors for patients with myocardial infarction and depressed left ventricular function. , 2000, Archives of internal medicine.

[40]  J. Yee,et al.  Risks associated with renal dysfunction in patients in the coronary care unit. , 2000, Journal of the American College of Cardiology.

[41]  L. Wallentin,et al.  Outcome at 1 year after an invasive compared with a non-invasive strategy in unstable coronary-artery disease: the FRISC II invasive randomised trial , 2000, The Lancet.

[42]  B. McNeil,et al.  Survival after acute myocardial infarction in patients with end-stage renal disease: results from the cooperative cardiovascular project. , 2000, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[43]  Bruce R. Brodie,et al.  Coronary Angioplasty with or without Stent Implantation for Acute Myocardial Infarction , 1999 .

[44]  G. Remuzzi,et al.  Uremic bleeding: closing the circle after 30 years of controversies? , 1999, Blood.

[45]  A. Collins,et al.  Poor long-term survival after acute myocardial infarction among patients on long-term dialysis. , 1998, The New England journal of medicine.

[46]  G. Barsotti,et al.  Bleeding and thrombosis in chronic uremia. , 1997, Nephron.

[47]  Frans Van de Werf,et al.  An international randomized trial comparing four thrombolytic strategies for acute myocardial infarction. , 1993, The New England journal of medicine.

[48]  B. Boneu,et al.  Pharmacokinetic Studies of Standard Unfractionated Heparin, and Low Molecular Weight Heparins in the Rabbit , 1988, Seminars in thrombosis and hemostasis.

[49]  Cockcroft Dw,et al.  Prediction of Creatinine Clearance from Serum Creatinine , 1976 .

[50]  E. Veys,et al.  Letter: HL-A and infective sacroileitis. , 1974, Lancet.